Martha A. Mendoza-Hernandez

Safety and efficacy of a COVID‑19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open‑label, controlled trial

Iván Delgado‐Enciso, Juan Paz-García, Carlos E Barajas-Saucedo et al. · Experimental and Therapeutic Medicine · 2021 · 27 citations · Full text

Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective

José Guzmán-Esquivel, Martha A. Mendoza-Hernandez, Hannah Priscila Guzman-Solorzano et al. · Healthcare · 2023 · 25 citations · Full text

A phase I–II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee

Iván Delgado‐Enciso, Juan Paz-García, Jose Valtierra‐Alvarez et al. · European journal of medical research · 2018 · 18 citations · Full text

Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial

Jos� Guzman‐Esquivel, Martha A. Mendoza-Hernandez, Daniel Tiburcio‐Jimenez et al. · Oncology Letters · 2020 · 14 citations · Full text

Inflammation, Urology, Anti-inflammatory +13

Improve cognitive impairment using mefenamic acid non-steroidal anti-inflammatory therapy: additional beneficial effect found in a controlled clinical trial for prostate cancer therapy.

Valery Melnikov, Daniel Tiburcio‐Jimenez, Martha A. Mendoza-Hernandez et al. · PubMed · 2021 · 14 citations · Full text

Neurochemical Biomarkers, Pharmacotherapy, Cognitive Rehabilitation +21